NEW YORK (GenomeWeb) – Singulex announced today that it has signed an agreement giving EMD Millipore, a unit of Germany's Merck KGaA, the rights to control and manage its life science research business, which includes the company's single-molecule counting (SMC) technology.

The SMC technology enables the detection of single molecules such as proteins and metabolites in complex biological samples. It is the basis for Singulex's research-use-only Erenna instrument, which can detect single molecules down to the femtogram level.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.